June 30, 2025 · Form 4 insider transaction
Rahmer Peter bought 5,000 shares of Relay Therapeutics, Inc. at $2.94 per share, a transaction worth $14.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.; In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025.; Includes 204,715 shares underlying RSUs.